EU ingredient rules · 1 min read
Bis-Isobutyl Peg-14/amodimethicone Copolymer in cosmetics: EU rules
Quick answer: Bis-Isobutyl Peg-14/amodimethicone Copolymer is a restricted cosmetic ingredient in the EU: Annex III (entry 186) allows it only within set limits, at up to 0.1% in the ready-to-use product. CosIng lists its functions as hair conditioning and hair fixing.
Key facts
| INCI name | BIS-ISOBUTYL PEG-14/AMODIMETHICONE COPOLYMER |
|---|---|
| EU status | Restricted (Annex III, entry 186) |
| Functions (CosIng) | Hair conditioning, Hair fixing |
CosIng description: Poly(oxy-2-methylbutylenepoly(3-(2-aminoethyl)aminopropyl methyl, dimethyl)silyleneoxy)dimethylsilylene-2-methylbutylenepoly(oxyethylene)) (14 mol EO average molar ratio)
What it does in a product
- Hair conditioning: Makes hair easier to comb and leaves it softer or shinier.
- Hair fixing: Helps hold a hairstyle in place.
Annex III: restricted substances, entry 186
Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.
The entry is listed as 2,2'-oxydiethanol Diethylene glycol (DEG)
Maximum concentration in the ready-to-use product: 0.1%
Product type or body part:
As traces in ingredients
Most recent legal act listed by CosIng for this entry: Regulation (EC) 2013/344.
Scientific Committee on Consumer Safety (SCCS) opinions:
Why it matters for shelf life
The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.
Not sure how to read a label? What an INCI name is · How ingredient lists work
Source
European Commission, CosIng (Cosmetic Ingredients database), entries for BIS-ISOBUTYL PEG-14/AMODIMETHICONE COPOLYMER and Annex III/186, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.